We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ASND market cap is 10.07B. The company's latest EPS is EUR and P/E is N/A.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 137.7M | 95.89M | 36M | 57.83M | 173.92M |
| Operating Income | -239.97M | -54.94M | -138.58M | -101.11M | -215.12M |
| Net Income | -86.88M | -131.04M | -109.38M | -99.2M | -38.47M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 4.35M | 5.41M | 48.63M | 266.72M | 363.64M |
| Operating Income | -340.14M | -439.75M | -579.51M | -473.94M | -298.82M |
| Net Income | -418.96M | -383.58M | -583.19M | -481.45M | -378.08M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 825.59M | 802.5M | 758.3M | 1.09B | 1.18B |
| Total Liabilities | 971.28M | 1.04B | 1.08B | 1.19B | 1.29B |
| Total Equity | -145.7M | -238.18M | -321.13M | -97.32M | -105.71M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 979.79M | 1.08B | 1.09B | 825.59M | 1.18B |
| Total Liabilities | 141.08M | 201.29M | 826.39M | 971.28M | 1.29B |
| Total Equity | 838.71M | 883.64M | 263.35M | -145.7M | -105.71M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -467.36M | N/A | N/A | -219.02M | -306.2M |
| Investing | 286.47M | N/A | N/A | 7.26M | 6.88M |
| Financing | 134.29M | N/A | N/A | 443.84M | 443.93M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -271.55M | -417.65M | -495.7M | -467.36M | -306.2M |
| Investing | -291.2M | -110.58M | 61.73M | 286.47M | 6.88M |
| Financing | 602.65M | 351.39M | 396.77M | 134.29M | 443.93M |
| Market Cap | 10.07B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 60.69M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 11.99 (7.02%) |
| Company Name | Ascendis Pharma AS |
| Address |
tuborg boulevard 12 hellerup 2900 |
| Website | https://www.ascendispharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
